BioCentury | Nov 18, 2019
Finance

How Quan intends to build cross-border start-ups with second fund

...U.K.-based Crescendo Biologics Ltd. Quan’s new fund has invested in three companies: CAR T company Arcellx Inc....
BioCentury | Nov 18, 2019
Finance

How Quan intends to build cross-border start-ups with its second fund

...U.K.-based Crescendo Biologics Ltd. Quan’s new fund has invested in three companies: CAR T company Arcellx Inc....
BioCentury | Oct 4, 2019
Emerging Company Profile

Arcellx debuts with $85M, tech for adapting CAR Ts

...it’s the adaptor protein rather than the T cell that needs to be modified, said Arcellx Inc....
...Existing investors Novo Holdings A/S, SR One, NEA and Takeda Ventures also participated. COMPANY PROFILE Arcellx Inc....
BioCentury | May 4, 2018
Targets & Mechanisms

Solid hopes for T cell bispecifics

...be delivered in a short, once-weekly IV infusion. David Hilbert, CEO of CAR T company Arcellx Inc....
...Oncology, Alexandria, Va. American Society of Hematology, Washington, D.C. Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Arcellx Inc....
Items per page:
1 - 4 of 4
BioCentury | Nov 18, 2019
Finance

How Quan intends to build cross-border start-ups with second fund

...U.K.-based Crescendo Biologics Ltd. Quan’s new fund has invested in three companies: CAR T company Arcellx Inc....
BioCentury | Nov 18, 2019
Finance

How Quan intends to build cross-border start-ups with its second fund

...U.K.-based Crescendo Biologics Ltd. Quan’s new fund has invested in three companies: CAR T company Arcellx Inc....
BioCentury | Oct 4, 2019
Emerging Company Profile

Arcellx debuts with $85M, tech for adapting CAR Ts

...it’s the adaptor protein rather than the T cell that needs to be modified, said Arcellx Inc....
...Existing investors Novo Holdings A/S, SR One, NEA and Takeda Ventures also participated. COMPANY PROFILE Arcellx Inc....
BioCentury | May 4, 2018
Targets & Mechanisms

Solid hopes for T cell bispecifics

...be delivered in a short, once-weekly IV infusion. David Hilbert, CEO of CAR T company Arcellx Inc....
...Oncology, Alexandria, Va. American Society of Hematology, Washington, D.C. Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Arcellx Inc....
Items per page:
1 - 4 of 4